Definitive Contract HHSF223200510006C

The Food and Drug Administration awarded a firm fixed price purchase order valued at one hundred seventy-one thousand seven hundred thirty-three dollars to Chemotargets S.l. to deliver a pharmacological mechanism-based safety prediction platform. As described in the original solicitation, FDA/Center for Drug Evaluation and Research sought a tool to predict potential secondary targets for new pharmaceuticals through data mining and analytics of chemical properties. The place of performance will...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Inflexxion, Inc., a for-profit organization, to improve the quality and representativeness of the Addiction Severity Index-Multimedia Version (ASI-MV) Network. This contract, with a potential value of $1,095,103.00, is associated with the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The contract does not have a set-aside designation and...

This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for the renewal of ADMET Predictor software licenses and associated support services. The contract, valued at $100,337.38, has an ultimate completion date of February 19, 2026. The original solicitation sought to renew the FDA's existing licenses for the ADMET Predictor software, which is used by the Center for Tobacco Products (CTP) for toxicology data mining and assessing the...

This is a firm fixed-price task order awarded by the Food and Drug Administration (FDA) under the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule to Fors Marsh Group LLC, a for-profit limited liability company and certified B Corporation. The $669,354.70 task order is for "DATA DISPLAY DISCLOSURES IN PROFESSIONAL AND CONSUMER PRESCRIPTION DRUG PROMOTION" services, classified under the "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" program. This...

The Food and Drug Administration awarded a firm fixed-price purchase order valued at approximately $596,157 to Caerus US 1 Inc. to provide access to the Pharmaprojects drug pipeline database under an existing indefinite-delivery/indefinite-quantity contract vehicle. The contract calls for a Citeline license with unlimited search capabilities of the Pharmaprojects database, which contains over 60,000 drug profiles from active development through market approval, along with development...

The Department of Health and Human Services Food and Drug Administration awarded a $2,877,830 firm fixed price delivery order contract to Biopharma Services USA Inc. for NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS. As a foreign owned, self-certified small disadvantaged business, Biopharma Services USA will conduct the in vivo study of generic drug products in human subjects to fulfill the FDA's major program of...

The Department of Health and Human Services Food and Drug Administration awarded a task order worth $531,215 to Westat, Inc. under the agency's Quick Turnaround Social Science Research Services Blanket Purchase Agreement call. The task order is titled "General Population Survey on Prescription Drug Promotion" and requires the contractor to conduct a survey to gather information from the general population on prescription drug promotion. Work will be performed in Potomac, Maryland...

The Department of Health and Human Services Food and Drug Administration awarded a definitive, cost-no-fee contract to the Alliance Nctn Foundation, a non-profit organization, for the "Adverse Event Reporting in the Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Initiative" with a potential value of $518,381.51. The contract, which does not have a set-aside designation, is for work to be performed in Chicago, Illinois and has a completion date of December 31,...

The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the...

This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,803 APREPITANT 40 MG CAPSULE UD 5S pharmaceutical products. The $1,006.68 award has a completion date of January 10, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has an extensive history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA programs. No set-aside...